(BFW) Draghi Says There’s Clear Evidence ECB Policy Is Effective



Draghi Says There’s Clear Evidence ECB Policy Is Effective
2015-04-17 20:36:09.938 GMT


By Stefan Riecher
(Bloomberg) -- “Financial-market conditions and the cost
of external finance for the private sector have eased
considerably over the past months and borrowing conditions for
firms and households have improved notably, with a pick-up in
the demand for credit,” ECB President Mario Draghi says in text
of statement to the IMFC in Washington.
* “We intend to purchase private and public securities until
end-September 2016. In any case, we will continue the
purchases until the Governing Council sees a sustained
adjustment in the path of inflation which is consistent with
its aim of achieving inflation rates below, but close to, 2%
over the medium term”
* “Regarding structural reforms, important steps have been
taken in several euro-area member states, while in others
measures still need to be implemented”
* NOTE: Link to statement
* NOTE: Draghi Shrugs Off Protest Shock to Signal Calm on
Economy


For Related News and Information:
First Word scrolling panel: FIRST<GO>
First Word newswire: NH BFW<GO>

To contact the reporter on this story:
Stefan Riecher in Washington at +49-69-92041-341 or
sriecher@bloomberg.net
To contact the editors responsible for this story:
Fergal O’Brien at +44-20-3525-7152 or
fobrien@bloomberg.net
Brendan Murray

>>> Weekly Update

Weekly Market Update: Dollar Retreats, Oil Rebounds


European and Chinese equity markets saw fresh record highs this week, while US equities approached record highs again. However Greek turmoil, the poor US March retail sales report and China's slate of weak March data eventually pulled markets lower. The China Securities Regulatory Commission helped vaporize a large chunck of April's gains by banning certain forms of margin trading. ECB QE and the Greece situation pulled the German 10-year yield down to all-time lows around 0.049% on Friday, while peripheral yields backed up, led by Greece. Oil prices broke out to the highs of the year on speculative bets we may have seen the peak US production figures, while the Dollar gave back some notable ground as traders unwound a portion of the recent relative strength trades tied to a more favorable US economic outlook. For the week, the DJIA lost 1.3%, the S&P500 dropped 1% and the Nasdaq was down 1.3%.

The most recent CPI inflation data appears to suggest the US inflation cycle may be turning, providing some support for Fed rate hikes sooner rather than later. On Friday, the March headline y/y CPI reading dipped into negative territory, however the core y/y CPI reading was a robust +1.8%, beating expectations by a tenth of a percent. March was the second consecutive month of gains in the core y/y CPI figure. Analysts suggest core inflation will continue higher in the tug-of-war between growing wages, lower import prices and the stronger dollar.

The advance March retail sales report missed expectations for the third month in a row, and there were downward revisions to core retail sales for January and February. The core reading, which excludes volatile categories, was up a mere 0.3%. Taken together, the data suggests the consumer was pretty weak in the first quarter, with negative implications for Q1 GDP (the advance reading is due later this month). Manufacturing data for April from the Philadelphia Fed and the New York Fed was mixed: the headline Philly Fed number was not bad while the Empire survey went negative for the first time since December. But more to the point, new orders in both reports were anemic.

A raft of Fed speakers this week mostly took the data in stride. On balance, the Fed continued to indicate that June will be a 'live' meeting for considering rate lift off, but only if the economy shakes off the seasonal weakness seen in Q1. Fed Vice Chair Stanley Fischer summarized by saying he expects some snap back in Q2 but its not clear what magnitude, and the timing of rate lift off remains data dependent.


Relations between Greece and its European partners decayed further. On Sunday, the EU gave Athens until April 20th to preset a new slate of reforms before they would unlock the final €7.2 billion tranche of aid funds at the Eurogroup meeting on April 24th. Various officials commented that little progress was being made in current negotiations and nobody expects any resolution ahead of the Eurogroup meeting. Late in the week, the FT reported that a Greek official told the paper "We have come to the end of the road. If the Europeans won't release bail-out cash, there is no alternative [to a default]." Though European officials at the IMF conference in Washington continued to insist that they want Greece to remain in the euro zone, Greece's neighbors were instituting measures to quarantine local branches of Greek banks and peripheral European bond yields soared.

Besides a feminist protestor breaking up the press conference with confetti, Wednesday's ECB decision was a snooze. President Draghi dwelled on the early successes of QE and again dismissed fears about a possible shortage of available bonds to buy. European bond yields kept sinking under the impact of QE and the Greek situation, with the German 10-year bund falling as low as 0.049% (a record low) while Italy and Spain 10-year yields soared more than 14 basis points and headed for 1.50% on Greek contagion fears. The euro gained steadily as the greenback softened on weaker US economic data. EUR/USD was as lows as 1.0530 on Monday and touched a high of 1.0850 on Friday.

The Canadian Dollar saw its biggest moves since the BoC's surprise rate cut in January. Three months ago, the BoC cut is key rate to 0.75% due to the sharp declines in oil and the implications for Canada's inflation outlook. Governor Poloz had left the door open to more rate cuts if needed, but this week the BoC withdrew any hint that it was planning to cut rates again. The staff GDP forecast for 2015 was lowered slightly but the outlook for 2016 was raised by a hair, while the overall CPI forecast for 2015 was raised quite a bit. USD/CAD had been in a 1.2350-1.2850 range since the cut; after the decision, USD/CAD dropped out of the range to around 1.2100.

Crude prices sustained their month-long rally this week on the weak dollar and slackening inventory builds. The API crude report saw its fifth straight build and the DoE report saw its 14th straight build, although the gains were both well below expectations. Over the week, the front-month WTI contract rose from $52 to a high of $57.42, notching a year to date high. Note that OPEC's monthly report out showed March production by the cartel of 30.79M bpd, +810K bpd driven by Saudi Arabia, Libya, Iraq. Saudi production grew to 10.29M bpd from 9.64M in February.

JPMorgan and Goldman Sachs beat first-quarter earnings expectations and saw good revenue growth. Goldman's revenues rose to a four-year high and the firm's investment banking net revenues saw its best quarter since 2007. Book value per share increased $5.38 to $168.39, the largest quarterly increase in over five years. Citigroup had a very good quarter, soundly beating earnings expectations on 16% growth in quarterly profit. However, revenue missed and declined slightly y/y. Mortgage lending giant Wells Fargo's earnings were flat y/y and slightly above expectations, while the firm saw solid revenue growth. Bank of America, PNC and US Bank disclosed lackluster quarterly numbers.

GE's revenue fell short of expectations, however the headline numbers reflected the GE Capital spinoff announced last week. The core industrial operation profit +9% y/y, improved profit margins sales +3% (including FX). Honeywell's revenue fell 5% y/y on FX and the Friction Material divestiture, while income saw modest gains. Shares of Netflix soared to all-time highs after beating expectations for net subscriber additions, both at home and abroad. A host of analysts upgraded the name and lavished praise on the firm's expansion, even as its earnings and revenue remained unspectacular.

M&A action was subdued this week. Nokia confirmed it had a deal in hand to acquire Alcatel-Lucent in an all-stock deal valued at €15.6B. Strong growth in high-speed mobile data connections for everything from driverless cars to robots was a key driver in the merger discussions. The development and rollout of 5G mobile networks will be the new firm's main objective. Activist hedge fund Jana Partners went after Qualcomm, confirming it has asked Qualcomm to consider separating its chip unit from its patent-licensing business.

The Shanghai Composite rose higher for the sixth straight week, tacking on another 6%, making for impressive rally of over 30% for the year. Investors have been undeterred by the apparent slowdown in the economy, as showcased by Q1 GDP and the bulk of data-points for the month of March. First quarter GDP growth of 7% was right in line with consensus and matched the overall 2015 target but still marked a 6-year low. Retail sales grew just 10.2% y/y, the slowest since February 2006 and missing forecasts. Industrial output grew 5.6%, the slowest since November 2008 and well below estimates at 7%e. Fixed-asset investment grew at a 14-year low of 13.5%.

Developments on Friday may put a big dent in the Chinese rally and by extension global equities. To help cut leverage and cool equity markets the China Securities Regulatory Commission banned the margin trading arms of brokerages from taking part in so-called "umbrella trusts", raising fears of a big China equity selloff. The regulator also placed limits on margin trading for highly risky small stocks that trade OTC, and warned the small investors driving the mainland equity rally not borrow money or sell property to buy stocks.

>>> US Close Dow-1,54% S&P-1,13% Nasdaq-1,52% Russell-1,64%

Closing Market Summary: S&P 500 Ends Week Below 50-Day Average

The major averages ended Friday with a broad-based retreat that caused the market to turn negative for the week. The S&P 500 lost 1.1%, ending the week lower by 1.0%, while the Russell 2000 (-1.6%) underperformed today, but ended the week in-line with the benchmark index.

For background on today's retreat, we must start with the overnight session when a widespread outage took all Bloomberg terminals offline, which prevented large investors around the globe from communicating with their peers. The outage was followed by a plunge in Hang Seng and China-linked futures after China Regulatory Commission announced plans to ban margin financing for over-the-counter trades while also increasing the number of stocks eligible for short selling to 1,100.

In all likelihood, participants saw the big slide in Asia with little news to account for the move at that time and responded by reducing their risk exposure. Interestingly, S&P futures hit their overnight low around the time when access to Bloomberg terminals was restored and large investors could communicate with others once again.

That being said, the cautious posture persisted through the European session with Greece-related concerns keeping investors on the defensive. To that point, overseas units of Greek banks have been asked to divest their Greek sovereign debt holdings to avoid contagion in the event of a default. The request was reportedly issued by various central banks with backing from the European Central Bank. As a result, investors showed increased demand for German bunds with the 10-yr yield ticking down to 0.08% after dropping as low as 0.05%. 

Meanwhile, U.S. Treasuries endured a volatile session. The 10-yr note rallied overnight, but that was followed by a morning retreat, which was followed by an intraday climb to a fresh high, dropping the benchmark yield three points to 1.86%.

As for stocks, the S&P 500 dropped below its 50-day moving average (2,085) during late-morning action and distanced itself from that level into the afternoon. Taking a look at the bigger picture, this week's retreat placed the benchmark index smack dab in the middle of a range (2,040-2,120) that has held since early February even though earnings estimates for Q1 have been reduced during that stretch.

Speaking of earnings, most of the reports released since yesterday's closing bell surpassed bottom-line estimates, but revenue growth and guidance left a lot to be desired. General Electric (GE 27.25, -0.03) was a good example as the industrial conglomerate reported what has become a customary one-cent beat while revenue fell 3.1% year-over-year. Similarly, Honeywell (HON 101.70, -2.22) reported a bottom-line beat, but lower guidance and below-consensus revenue sent the stock lower by 2.1%.

Moving to other cyclical sectors, financials (-1.3%) finished near the bottom of the barrel with American Express (AXP 77.32, -3.59) contributing to the relative weakness. The Dow component lost 4.4% after its earnings beat was overshadowed by light revenue.

Elsewhere, the consumer discretionary sector (-1.5%) also finished among the laggards with media names extending their losses during the afternoon after Bloomberg reported that federal regulators are leaning in favor of opposing the proposed merger between Time Warner Cable (TWC 149.61, -8.59) and Comcast (CMCSA 58.42, -1.25). The two names ended lower by 5.4% and 2.1%, respectively. On the flip side, toymaker Mattel (MAT 26.74, +1.48) escaped the broad pressure, climbing 5.8% after reporting better than expected results.

All in all, the six cyclical sectors lost between 0.8% and 1.5% while the countercyclical side was treated to a lighter shade of red with the four
defensively-oriented
groups falling between 0.3% and 0.9%.


Today's trading volume surpassed recent averages thanks to a boost from options expiration with more than 865 million shares changing hands at the NYSE floor.

Economic data included CPI, Leading Indicators, and Michigan Sentiment:
  • Consumer prices increased 0.2% for a second consecutive month in March while the consensus expected an increase of 0.3% 
    • Energy prices rose 1.1% in March after increasing 1.0% in February 
      • Gasoline prices, one of the main drivers of the increase in energy costs, rose 3.9% in March after increasing 2.4% in February 
    • Food prices declined 0.2% in March after increasing 0.2% in February 
    • Excluding food and energy, core CPI increased 0.2% for a third consecutive month in March while the consensus expected an increase of 0.1% 
  • The Conference Board's Leading Economic Index increased 0.2% in March after increasing a downwardly revised 0.1% (from 0.2%) in February while the consensus expected an increase of 0.3%. 
  • The University of Michigan Consumer Sentiment Index increased to 95.9 in the preliminary April reading from 93.0 in March while the consensus expected an increase to 94.0 
    • Consumer sentiment recovered the entire decline from February (95.4) despite relatively higher gasoline costs and a significant weakening in the latest payrolls data. 
    • The Current Conditions Index increased to 108.2 in April from 105.0 in March. The Expectations Index increased to 88.0 from 85.3. 
Monday's session will be free of economic data.
  • Nasdaq Composite +4.1% YTD 
  • Russell 2000 +4.0% YTD 
  • S&P 500 +1.1% YTD 
  • Dow Jones Industrial Average UNCH YTD 

(BN) Teva Is Said to Explore Mylan Bid to Create Generic-Drug Giant



Teva Is Said to Explore Mylan Bid to Create Generic-Drug Giant
2015-04-17 18:22:34.156 GMT


By Ed Hammond, Manuel Baigorri and David Wainer
(Bloomberg) -- Teva Pharmaceutical Industries Ltd. is
exploring a takeover offer for Mylan NV, people with knowledge
of the matter said, in a move that would create a global
generic-drug giant.
Teva hasn’t made a formal approach yet, the people said,
though Mylan is aware of the Israeli company’s interest. Teva is
evaluating the purchase internally and has also approached
advisers about the potential bid and financing, the people said,
asking not to be identified discussing private information.
The deliberations may not lead to an offer, the people
cautioned. Mylan would be a very large purchase for Teva Chief
Executive Officer Erez Vigodman, who has been in the position
for just over a year. Also, Mylan earlier this month set up a
mechanism under Dutch securities law that could make a takeover
more difficult.
A Teva purchase of Mylan has long been anticipated by
analysts who see a combination of two large generic drugmakers
as an opportunity to boost market share and cut costs. Mylan
this month made an unsolicited $28.9 billion bid for Perrigo
Co., which many see as a trigger for Teva to act before Mylan
becomes an even larger target.
Though Perrigo has said it will consider the offer, it
hasn’t publicly responded to the bid yet.
Teva spokeswoman Denise Bradley declined to comment on the
matter. Nina Devlin, a spokeswoman for Mylan, didn’t immediately
reply to a request for comments. After its shares gained 18
percent this year in Tel Aviv trading, Teva has a market value
of about $57 billion. Mylan’s market value is closer to $33
billion.

Takeover Spree

The pharmaceutical industry has been in the grip of a
takeover spree -- as companies look for new products and
pipelines to offset a fall in sales. Teva is no exception: The
company’s top selling drug, Copaxone, will compete with generic
copies this year, and its executives have been vocal about their
appetite for acquisitions.
Novartis AG’s Sandoz unit on Thursday won approval to make
a generic version of the multiple sclerosis treatment. Mylan has
also sought approval to market generic Copaxone, though its
version hasn’t been approved yet.

For Related News and Information:
Teva Set to Resume Deals After Investors Reward Rivals: Real M&A
Pharma’s Comeback Deals Keep Drug M&A on Track to Reach Records
Top Stories:TOP<GO>

--With assistance from Tara Lachapelle and Cynthia Koons in New
York and Matthew Campbell in London.

To contact the reporters on this story:
Ed Hammond in New York at +1-212-617-1963 or
ehammond12@bloomberg.net;
Manuel Baigorri in London at +44-20-3525-4457 or
mbaigorri@bloomberg.net;
David Wainer in Tel Aviv at +972-3-542-7110 or
dwainer3@bloomberg.net
To contact the editors responsible for this story:
Mohammed Hadi at +1-212-617-2914 or
mhadi1@bloomberg.net;
Aaron Kirchfeld at +44-20-3525-8830 or
akirchfeld@bloomberg.net
Elizabeth Fournier

NY Post : Spilled soda on server may have cause Bloomberg blackout

The more than two-hour blackout of of a “significant” number of Bloomberg data terminals in Europe and Asia wasn’t cause by terrorism or a natural disaster — but possibly by soda spilled by a clumsy IT worker.
That’s the chatter inside Bloomberg’s London offices after service was restored at about 10:30 a.m. London time, after almost two-and-a-half hours of no service, according to a report.
While the company’s official line is that the embarrassing — and costly — blackout was caused by “an internal network issue,” employees inside Bloomberg’s London offices, where the newsroom and television operations are located, are buzzing about “someone spilling a can of coke on a server somewhere,” a source told Business Insider, which first reported the possible cause of tech meltdown.
The blackout of the terminals, used by more than 300,000 people around the world, likely sent thousands of bankers and traders into a tizzy as it came at the close of Asian markets and just as Europe’s trading day go under way.
Some bond trades were cancelled as a result of the tech snafu.
The cause of the blackout is under investigation, Bloomberg said.
“Significant but not all parts of our network experienced a disruption today,” Bloomberg said in a statement. “We have restored service to most customers and are making progress in bringing all parts of the network back online. We apologize to our customers.”

>>>CSRC: brokers forbidden to do off-exchange stock financing

CSRC: brokers forbidden to do off-exchange stock financing or sell umbrella trusts

CSRC: brokers forbidden to do off-exchange stock financing or sell umbrella trusts

BEIJING, Apr.17 (Xinhua) -- Chinese brokerages shall not conduct off-exchange stock financing or sell umbrella trust products in any fashion, China's top securities regulator China Securities Regulatory Commission (CSRC) said on Friday.

According to a statement posted on CSRC's website, Zhang Yujun, assistant chairman of CSRC, said at a meeting with securities dealers on Thursday that margin trading businesses have been growing rapidly in China, and now the entire industry must pay great attention to regulation compliance and risk control when taking part in margin trading businesses.

In a margin trading, investors use their own money for only a portion of their stock purchases, and borrow the rest from brokerages. Umbrella trusts allow investors to secure more financing for stock purchases than normally allowed. (

>>> Halliburton retains Deutsche Bank and BofA for USD 5bn asset sales

Halliburton retains Deutsche Bank and BofA for USD 5bn asset sales 

Halliburton Company (NYSE: HAL), a US-based provider of products and services to the energy industry, has retained Deutsche Bank AG and Bank of America Corp to conduct the divestiture of two of its businesses valued at up to USD 5bn, a newswire reported citing sources close to the situation.

According to Reuters, Deutsche Bank is conducting the sale of the drill bits business, valued in the area of USD 1.5bn - USD 2bn, while Bank of America is retained to find a buyer for certain parts of the company's Sperry Drilling business, worth USD 3bn.

Halliburton announced on 7 April that it would divest three segments as a result of an antitrust review on its pending USD 34.6bn merger with Baker Hughes (NYSE: BHI). It said it would separately market its fixed cutter and roller cone drill bits, its directional drilling business, and its logging-while-drilling/measuring-while-drilling (LWD/MWD) business.

This services recently reported that Halliburton's drill bit unit will likely attract bids from international industrial concerns as well as the expected private equity-backed enterprises and large oilfield services strategics. Potential suitors could include industrial companies like Siemens (FRA: SIE), Sandvik (STO: SAND), Dover Corporation (NYSE: DOV), and ABB (VTX: ABBN) or strategic bidders like National Oilwell Varco (NYSE: NOV) and Superior Energy Services (NYSE: SPN). PE-firms including TPG Capital, KKR, Energy Capital Partners, Macquarie Infrastructure, Intervale Capital and First Reserve could also take a look, the analysis said.

According to the Reuters article, Halliburton could sell other assets as well as it continues to be in talks with antitrust regulators.

Credit Suisse, Halliburton's adviser on the Baker Hughes deal, is also taking part in the auction processes as global coordinator, the item noted.

Halliburton said earlier that it expects to complete the sale of the above mentioned businesses in the same timeframe as the closing of the pending Baker Hughes acquisition late in the second half of 2015.

>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance
: CHKE +13.2%, CE +13.2%, MAT +7.4%, SM +3.7%, FHN +3.1%, CYT +2.8%, SLB +2.6%, ANCX +2.3%, RAI +1.4%, MUX +1%, MFLX +0.7%, CMA +0.5%

M&A news: UNXL +17.8% (acquires Atmel's (ATML) XSense assets and operations), IGTE +7.5% (Capgemini (CGEMY) and Atos M&A speculation), HCBK +5.9% (Hudson City Banc and M&T Bank (MTB) have agreed to extend the date after which either party may elect to terminate their Agreement and Plan of Merger)

Other news: RXII +24.3% (confirms its receives Orphan Drug Designation for Samcyprone from the FDA to treat malignant melanoma ), TRXC +21% (Announces Completion of GLP Studies; SurgiBotTM system FDA 510(k) filing on track for mid-2015 submission), ONCY +15.9% (confirms its receipt of Orphan Drug Designation from the FDA for REOLYSIN), NVGN +14.4% (signs an MOU with the Feinstein Institute for Medical Research to collaborate on developing treatments for brain cancers), GMO +14% (announces strategic partnership with AMER International Group to become a major shareholder), SSH +5.8% (announces that the FDA has reviewed co's submission regarding the COUNTER HF's U.S. pivotal study pause and requested minor protocol changes be submitted in order to receive approval to resume patient enrollment ), HOT +4% (may be a possible activist target, according to Bloomberg), GIG +3.7% (Fred H. Brenner disclosed 7.05% passive stake in 13G filing), SM +3.7% (announced that Q1 production is expected to be 16.8 MMBOE, or 186.4 MBOE/d; borrowing base maintained at $2.4 bln), BSX +1.8% (enrolls first patient in new study designed to demonstrate the effect of the Vessix Renal Denervation System), ARIA +1.6% (announces updated clinical data on Brigatinib to treate ALK+ non-small cell lung cancer), ARCO +1.5% ( announces that coffee sales at McDonald's (MCD) Brazil set a new 7-day record in early April, serving 66 mln liters between April 1 and April 7, up 34% from the same period a year ago)

Analyst comments: ROSG +6.1% (upgraded to Buy from Hold at Cantor Fitzgerald), CYTR +4% (initiated with an Outperform at Oppenheimer), MNTA +2.9% (target raised to $24 from $16 at Leerink Partners; Outperform; also announced the upcoming presentation of two posters), ICPT +2.6% (initiated with a Buy at UBS), OPWR +1.4% (initiated with an Outperform at William Blair),RCPT +0.8% (initiated with a Buy at UBS), CYBR +0.8% (initiated with a Mkt Outperform at JMP Securities), RGC +0.6% (initiated with a Outperform at RBC Capital Mkts)

>>> US Gapping down

Gapping down
In reaction to disappointing earnings/guidance
: PRO -15.4%, AMD -10.5%, NOW -9.3%, STRM -9.3%, MTW -5.8%, TC -4.5%, AXP -1.8%, CCK -1.2%, HON -0.6%, DB -2.9%, ING -2.6%, SAN -2.5%, BBVA -2.1%

Other news: ATHX -52.2% (interim results from its MultiStem study in which the therapy failed to meet primary or secondary endpoints), DSCO -21.7% (completes enrollment of AEROSURF Phase 2a Clinical Trial and restructures its business to focus on development of AEROSURF and Aerosolized KL4 Surfactant pipeline ), MNGA -7.1% (provides statement regarding accident at its Tarpon Springs, Florida facility), WPCS -5.2% (following a Special Meeting the Board determined it was in the best interests of the Company to effect a reverse split of the issued and outstanding common stock at a ratio of 1-for-22), AKBA -5.2% (prices 7,272,727 shares of common stock at $8.25 per share), SNE -4.8% (following NPD data), TC -4.5% (reported Q1 total concentrate production for Mount Milligan was 30.3 thousand dry tonnes, with 15.4 mln pounds of payable copper and 46.k ounces of payable gold), WUBA -4.5% (acquires strategic stake in Ganji.com and announces additional investment by Tencent (TCEHY)), ASND -3.5% ( discloses that its collaboration partner, Sanofi (SNY) has decided to cease development of TransCon Insulin ), PTX -1.7% (priced its private offering of $130 mln aggregate principal amount of the Company's 4.25% Convertible Senior Notes due 2021 ), PBR -1.6% (announces that its oil and natural gas output in Brazil), QGEN -1.5% (still checking), WYNN -1.5% (Steve Wynn responds to recent press release by Elaine Wynn)

Analyst comments: MT -3.7% (downgraded to Underperform from Neutral at Exane BNP Paribas), HAIN -3.5% (downgraded to Neutral from Buy at Longbow ), ZUMZ -2.5% (downgraded to Neutral from Buy at B. Riley & Co), FLS -1.4% (downgraded to Perform from Outperform at Oppenheimer), LION -1.2% (downgraded to Mkt Perform from Outperform at Keefe Bruyette), FUL -1.1% (downgraded to Equal-Weight from Overweight at First Analysis Sec), RGA -1% (downgraded to Mkt Perform from Outperform at Raymond James), TRV -0.8% (downgraded to Equal Weight from Overweight
)

(UBS) European IT : iGate reported to be in talks with ATOS and CAP (pdf att.)

Full note attached

* iGate – a US-centred offshore provider
India's Business Standard newspaper reported yesterday that both Capgemini and Atos
are in talks to acquire iGATE, a Nasdaq-listed 33,500-person offshore heritage business,
although the companies have not commented on the report. Over 27,500 of its staff
are based offshore, while over 5,000 are in the US, and the rest in Europe. Over three
quarters of sales are made into the US, 15% or so into Europe and 5% into Asia.
Offshore effort makes up about three quarters of activity, with two thirds of sales
coming from long-term contracts (including BPO), and a third from time-and-materials
activities. In 2014, it had sales of $1,268m (+10%) with an EBITDA of $276m/22%. By
industry, Banking and Insurance makes up about 40% of sales, Manufacturing 25%;
Healthcare 10% and Retail 10%. The top 5 clients make up nearly 40% of sales, with
GE (16%) and RBC (10%) its largest customers.

* Does a deal make sense?
Atos and Capgemini both want a greater US presence, and Atos also wants to jumpstart
its offshore position (18k/21% vs 68k/47% at Capgemini). Capgemini has talked
of expanding its healthcare exposure in the US also, having sold-out to Accenture in
2005. While iGate has a useful exposure here, its large Banking and Insurance practice
is bigger, but would fit with Capgemini's strengths here nicely. For Atos, with Bull and
Xerox integration ongoing as well as iGate's high valuation, we question how willing it
would be to get into a bidding war for iGate.

* What are the financial implications?
iGate's shares are near post-2000 highs giving it a $3.4bn market capitalisation and it
trades at a 19x 2016E cons. PE and 10.8x EV/EBITDA. Assuming a 30% premium and
before any synergies are considered (likely modest anyway), we see similar c.16-18%
PBT accretion for Atos and Capgemini in 2016/17E, although Capgemini would get
additional cash tax benefits from its E&Y tax shield. For iGate, if it sold to Capgemini it
would be clearly subsumed into a much larger business than Atos, but one with a more
proven understanding of how to make offshoring work. If Atos acquired it (which we
see less likely), it would be able to shape the offshore proposition more clearly.